1. Home
  2. EHC vs PODD Comparison

EHC vs PODD Comparison

Compare EHC & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

SELL

Current Price

$127.76

Market Cap

11.2B

Sector

Health Care

ML Signal

SELL

Logo Insulet Corporation

PODD

Insulet Corporation

SELL

Current Price

$141.64

Market Cap

10.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EHC
PODD
Founded
1983
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
10.2B
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
EHC
PODD
Price
$127.76
$141.64
Analyst Decision
Strong Buy
Buy
Analyst Count
13
26
Target Price
$148.17
★ $167.17
AVG Volume (30 Days)
880.8K
★ 1.3M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 0.66%
N/A
EPS Growth
★ 24.22
N/A
EPS
★ 3.47
2.67
Revenue
N/A
★ $2,708,100,000.00
Revenue This Year
$8.84
$21.37
Revenue Next Year
$8.26
$13.57
P/E Ratio
★ $36.90
$51.96
Revenue Growth
N/A
★ 30.73
52 Week Low
$92.77
$126.40
52 Week High
$129.96
$354.88

Technical Indicators

Market Signals
Indicator
EHC
PODD
Relative Strength Index (RSI) 64.54 55.87
Support Level $118.99 $139.67
Resistance Level N/A $143.45
Average True Range (ATR) 2.66 3.53
MACD 0.50 1.15
Stochastic Oscillator 78.56 86.30

Price Performance

Historical Comparison
EHC
PODD

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: